On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
We have now added a new section called the "Assay History List" to the "At A Gla...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On February 18, 2019, the New CTS Laboratory Information System has been successfully implemented in...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...